Insulet Files for Secondary Offering

Diabetes-management firm Insulet (NASDAQ: PODD) of Bedford, MA, filed with the SEC for a secondary public offering of some 4.8 million shares. Insulet went public in May with an offering of 7.7 million shares at $15 per share. The stock closed Friday at $23.77.

Rebecca is Xconomy's co-founder. Follow @

Trending on Xconomy